難聴治療の市場規模、シェア、動向分析レポート：製品別、疾患別、最終用途別、地域別、セグメント予測、2025年～2030年

難聴治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、難聴治療の世界市場規模は2025年から2030年にかけてCAGR 7.29％を記録し、2030年には175億1,000万米ドルに達すると予測されています。

この成長の背景には、世界の疾病負担の増加、人々の意識を広めるために政府や民間団体が行っている取り組み、世界の老人人口の増加があります。さらに、臨床パイプライン医薬品の増加や聴覚デバイスの進歩は、業界の成長に有利な機会を提供します。世界では難聴患者が増加しており、これが業界の成長を促進する主な要因となっています。

例えば、WHOの報告によると、2021年には世界人口の5%以上、約4億3,000万人が聴力障害を管理するためのリハビリテーションを必要とします。さらに、2050年には世界中で約25億人が聴力障害の影響を受けると推定されています。報告書によると、低・中所得国が障害に苦しむ人々の80％を占めています。高齢化がさらに有病率の上昇につながっています。世界全体では、60歳の約25％が難聴に罹患しています。従って、疾病の増加は治療需要を増加させ、この分野を牽引しています。この分野には強固な臨床試験パイプラインが存在し、今後数年間でより良い治療オプションが提供されると期待されています。

これは、臨床試験のさまざまな段階にある45以上の治療法の存在によって予想されます。例えば、Sound Pharmaceuticals社のEbselenとSensorion社のSENS-401は、それぞれメニエール病と感音性難聴の治療を適応とする第3相臨床試験中です。同様に2022年6月には、パイプライン・セラピューティクス社の第2相試験薬PIPE-505が感音性難聴を対象に評価されています。したがって、今後数年間における新たな治療オプションの発売は、業界に有利な機会を提供すると予想されます。聴覚製品におけるAI関連イノベーションなどの技術進歩の高まりが業界を後押ししています。

スマートフォンでの操作や充電式＆防水デバイスなど、高度な機能を備えた製品の発売は、顧客体験を向上させています。例えば、GNヒアリングは2022年6月、AndroidやiOSからのワイヤレスストリーミングに対応した充電式補聴器「Custom made by Resound」を発売しました。主要企業は、新発売、提携、契約、財務投資などの戦略的イニシアチブを実施しており、これが業界をさらに牽引しています。例えば、2022年4月、オーティジェンはベーリンガーインゲルハイムと、感音性疾患に苦しむ人々のための先進的な治療法を開発するための共同研究およびライセンス契約を締結しました。同様に、2022年9月、Fennec Pharmaceuticalsは、Pedmarktoが化学療法を受ける小児患者の難聴を防ぐというFDAの承認を発表しました。

難聴治療市場レポートハイライト：

• 2024年にはデバイス分野が業界を支配し、全体の収益の91.02%以上の最大シェアを占めました。これは、デバイスの技術的進歩、デバイスの利点の高まりと相まって高い普及率に起因します。
• 薬剤セグメントは、新しい治療製品の発売により、予測期間中に最も速いCAGRを記録すると推定されています。薬剤はいくつかのタイプの聴覚障害に利用可能です。
• 感音性難聴分野は2024年に業界を支配し、総収入の65.24％以上の最大シェアを占め、予測期間で最も急成長する分野と予測されます。
• 北米難聴治療産業は、2024年に世界シェアの31.32％を占め、主導的地位を占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 難聴治療市場の変数、動向、範囲

• 市場系統の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 社会的スティグマの存在
• 低中所得国（LMIC）における不十分な償還制度
• ビジネス環境分析
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析
  • パイプライン分析

第4章 難聴治療市場：製品別ビジネス分析

• 製品市場シェア、2024年および2030年
• 製品セグメントダッシュボード
• 市場規模、予測、動向分析（製品別、2018～2030年）
• デバイス
• 薬物

第5章 難聴治療市場：疾患別ビジネス分析

• 疾病市場シェア、2024年および2030年
• 疾患セグメントダッシュボード
• 市場規模、予測、動向分析（疾患別、2018～2030年）
• 伝音性難聴
• 感音難聴
• 混合型（伝音性と感音性）

第6章 難聴治療市場：エンドユーザー別ビジネス分析

• エンドユーザー市場シェア、2024年および2030年
• エンドユーザーセグメントダッシュボード
• 市場規模、予測、動向分析（最終用途別、2018～2030年）
• 病院
• 耳鼻科クリニック
• 外来診療所

第7章 難聴治療市場：地域別推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 市場規模と予測動向分析、2018年から2030年まで：
• 北米
  • 国別、2018年～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東およびアフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/リスト
  • Novartis AG
  • Spiral Therapeutics（Otonomy, Inc.）
  • Acousia Therapeutics Gmbh
  • Sensorion
  • Audina Hearing Instruments, Inc.
  • Ws Audiology A/S
  • audifon Gmbh &Co. Kg
  • MED-EL Medical Electronics
  • Demant A/S
  • Sonova

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 List of Parameters
• Table 4 List of Distributors
• Table 5 Global Hearing Loss Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 6 Global Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 7 Global Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 8 Global Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 9 North America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 10 North America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 11 North America Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 12 North America Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 15 U.S. Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 16 Canada Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 17 Canada Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 18 Canada Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 19 Mexico Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 20 Mexico Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 21 Mexico Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 22 Europe Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 23 Europe Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 24 Europe Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 25 Europe Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 26 Germany Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 27 Germany Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 28 Germany Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 29 UK Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 30 UK Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 31 UK Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 32 France Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 33 France Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 34 France Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 35 Italy Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 36 Italy Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 37 Italy Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 38 Spain Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 39 Spain Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 40 Spain Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 41 Denmark Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 42 Denmark Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 43 Denmark Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 44 Sweden Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 45 Sweden Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 46 Sweden Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 47 Norway Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 48 Norway Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 49 Norway Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 54 Japan Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 55 Japan Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 56 Japan Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 57 China Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 58 China Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 59 China Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 60 India Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 61 India Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 62 India Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 63 South Korea Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 64 South Korea Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 65 South Korea Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 66 Australia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 67 Australia Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 68 Australia Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 69 Thailand Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 70 Thailand Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 71 Thailand Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 72 Latin America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 73 Latin America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 74 Latin America Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 75 Latin America Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 76 Brazil Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 77 Brazil Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 78 Brazil Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 79 Argentina Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 80 Argentina Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 81 Argentina Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 84 Middle East & Africa Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 85 Middle East & Africa Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 89 South Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 90 South Africa Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 91 South Africa Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 92 UAE Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 93 UAE Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 94 UAE Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
• Table 95 Kuwait Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 96 Kuwait Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
• Table 97 Kuwait Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market summary
• Fig. 8 Market trends & outlook
• Fig. 9 Market segmentation & scope
• Fig. 10 Market driver relevance analysis (Current & future impact)
• Fig. 11 Market restraint relevance analysis (Current & future impact)
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Hearing Loss Disease Treatment Market - PESTLE Analysis
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Hearing Loss Disease Treatment Market Outlook Key Takeaways
• Fig. 16 Hearing Loss Disease Treatment Market: Product Movement Analysis
• Fig. 17 Global Hearing Loss Disease Treatment Market, by Product, 2018 - 2030 (USD Million)
• Fig. 18 Global Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 19 Global Devices Market, 2018 - 2030 (USD Million)
• Fig. 20 Global Drugs Market, 2018 - 2030 (USD Million)
• Fig. 21 Global Systemic Steroids Market, 2018 - 2030 (USD Million)
• Fig. 22 Global Antiviral Medication Market, 2018 - 2030 (USD Million)
• Fig. 23 Global Vasodilators Market, 2018 - 2030 (USD Million)
• Fig. 24 Global Hearing Loss Disease Treatment Market: Disease Movement Analysis
• Fig. 25 Global Hearing Loss Disease Treatment Market, by Disease, 2018 - 2030 (USD Million)
• Fig. 26 Global Conductive Hearing Loss Market, 2018 - 2030 (USD Million)
• Fig. 27 Global Sensorineural Hearing Loss Market, 2018 - 2030 (USD Million)
• Fig. 28 Global Mixed Hearing Loss Market, 2018 - 2030 (USD Million)
• Fig. 29 Global Hearing Loss Disease Treatment Market: End-User Movement Analysis
• Fig. 30 Global Hearing Loss Disease Treatment Market, by End-User, 2018 - 2030 (USD Million)
• Fig. 31 Global Otology Clinics Market, 2018 - 2030 (USD Million)
• Fig. 32 Global Hospitals Market, 2018 - 2030 (USD Million)
• Fig. 33 Global Ambulatory Clinics Market, 2018 - 2030 (USD Million)
• Fig. 34 Regional Market: Key Takeaways
• Fig. 35 Hearing Loss Disease Treatment Market Regional Outlook, 2018 & 2030
• Fig. 36 North America Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 37 U.S. Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 38 Canada Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 39 Mexico Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 40 Europe Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 41 Germany Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 42 UK Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 43 France Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 44 Italy Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 45 Spain Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 46 Denmark Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 47 Sweden Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 48 Norway Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 49 Asia Pacific Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 50 Japan Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 51 China Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 52 India Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 53 South Korea Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 54 Australia Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 55 Thailand Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 56 Latin America Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 57 Brazil Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 58 Argentina Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East & Africa Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 60 South Africa Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 62 UAE Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 63 Kuwait Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
• Fig. 64 Strategy Frameworks

Hearing Loss Disease Treatment Market Growth & Trends:

The global hearing loss disease treatment market size is expected to reach USD 17.51 billion by 2030, registering a CAGR of 7.29% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the global rise in disease burden, initiatives undertaken by government and private organizations to spread awareness among people, and the growing geriatric population in the world. Furthermore, the increasing number of clinical pipeline drugs and advancements with auditory devices offer lucrative opportunities for industry growth. The world is witnessing an increasing prevalence of hearing loss cases, which is the key factor driving the industry's growth.

For instance, according to the WHO reports, in 2021, over 5% of the world's population, or around 430 million people, require rehabilitation to manage their listening disability. Moreover, by 2050, nearly 2.5 billion people are estimated to be impacted by listening impairment across the globe. As per the report, low- and middle-income countries account for 80% of people suffering from a disability. Aging has further led to an increase in the prevalence of the disease. Globally, approximately 25% of people aged 60 years are affected by hearing loss. Therefore, the rising disease cases increase the demand for treatment and drive the space. The space has the presence of a robust clinical trial pipeline, which is expected to offer better treatment options in the coming years.

This can be anticipated due to the presence of more than 45 therapies at different phases of clinical investigation. For instance, Sound Pharmaceuticals' Ebselen and Sensorion's SENS-401 are under phase 3 clinical studies indicated for the treatment of Meniere's Disease and sensorineural hearing loss, respectively. Similarly, in June 2022, Pipeline Therapeutics' phase 2 drug, PIPE-505 is being evaluated for sensorineural hearing loss. Therefore, the launch of new treatment options in the coming years is expected to offer a lucrative opportunity for the industry. Rising technological advancements, such as AI-associated innovations, in auditory products, are boosting the industry.

The launch of products with advanced features like operating through smartphones and rechargeable & waterproof devices is enhancing customer experience. For instance, in June 2022, GN Hearing launched Custom made by Resound, a chargeable hearing aid that supports wireless streaming from Android and iOS. Key players are implementing strategic initiatives, such as new launches, collaborations, agreements, and financial investments, which are further driving the industry. For instance, in April 2022, Autigen entered into a collaboration and licensing agreement with Boehringer Ingelheim to develop advanced therapies for people suffering from sensorineural conditions. Similarly, in September 2022, Fennec Pharmaceuticals announced the FDA approval for Pedmarkto prevents hearing loss in pediatric patients going through chemotherapy.

Hearing Loss Disease Treatment Market Report Highlights:

• The devices segment dominated the industry in 2024 and accounted for the maximum share of more than 91.02% of the overall revenue. This can be attributed to technological advancements in devices, high prevalence coupled with the rising benefits of devices.
• The drugs segment is estimated to register the fastest CAGR over the forecast period due to the launch of new therapeutic products. Drugs are available for several types of hearing problems.
• The sensorineural hearing loss segment dominated the industry in 2024 and accounted for the maximum share of more than 65.24% of the total revenue and is estimated to be the fastest growing segment over the forecast period.
• North America hearing loss disease treatment industry held the leading position in 2024, accounting for 31.32% of the global share

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Disease
  • 1.2.3. End User
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Hearing Loss Disease Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increase in the number of patients with hearing loss
    • 3.2.1.2. Strong research and development pipeline
    • 3.2.1.3. Technological advancements in hearing aids
  • 3.2.2. Market Restraint Analysis
• 3.3. 3.3.1 Presence of social stigmas
• 3.4. 3.3.2 Poor reimbursement facilities in low- and middle-income countries (LMICs)
• 3.5. Business Environment Analysis
  • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.5.1.1. Supplier Power
    • 3.5.1.2. Buyer Power
    • 3.5.1.3. Substitution Threat
    • 3.5.1.4. Threat of New Entrants
    • 3.5.1.5. Competitive Rivalry
  • 3.5.2. PESTLE Analysis
  • 3.5.3. Pipeline Analysis

Chapter 4. Hearing Loss Disease Treatment Market: Products Business Analysis

• 4.1. Products Market Share, 2024 & 2030
• 4.2. Products Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Products, 2018 to 2030 (USD Million)
• 4.4. Devices
  • 4.4.1. Devices Market, 2018 - 2030 (USD Million)
• 4.5. Drugs
  • 4.5.1. Drugs Market, 2018 - 2030 (USD Million)
  • 4.5.2. Systemic steroids
    • 4.5.2.1. Systemic steroids Market, 2018 - 2030 (USD Million)
  • 4.5.3. Antiviral medication
    • 4.5.3.1. Antiviral medication Market, 2018 - 2030 (USD Million)
  • 4.5.4. Vasodilators
    • 4.5.4.1. Vasodilators Market, 2018 - 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Hearing Loss Disease Treatment Market: Disease Business Analysis

• 5.1. Disease Market Share, 2024 & 2030
• 5.2. Disease Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Disease, 2018 to 2030 (USD Million)
• 5.4. Conductive Hearing Loss
  • 5.4.1. Conductive Hearing Loss Market, 2018 - 2030 (USD Million)
• 5.5. Sensorineural Hearing Loss
  • 5.5.1. Sensorineural Hearing Loss Market, 2018 - 2030 (USD Million)
• 5.6. Mixed (Conductive and Sensorineural)
  • 5.6.1. Mixed (Conductive and Sensorineural) Market, 2018 - 2030 (USD Million)

Chapter 6. Hearing Loss Disease Treatment Market: End User Business Analysis

• 6.1. End User Market Share, 2024 & 2030
• 6.2. End User Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End User, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 6.5. Otology clinics
  • 6.5.1. Otology clinics Market, 2018 - 2030 (USD Million)
• 6.6. Ambulatory clinics
  • 6.6.1. Ambulatory clinics Market, 2018 - 2030 (USD Million)

Chapter 7. Hearing Loss Disease Treatment Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Hearing Loss Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Reimbursement Framework
    • 7.4.2.5. U.S. Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Reimbursement Framework
    • 7.4.3.5. U.S. Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Reimbursement Framework
    • 7.4.4.5. Mexico Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement Framework
    • 7.5.2.5. UK Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement Framework
    • 7.5.3.5. Germany Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement Framework
    • 7.5.4.5. France Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Target Disease Prevalence
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Reimbursement Framework
    • 7.5.5.5. Italy Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Target Disease Prevalence
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Reimbursement Framework
    • 7.5.6.5. Spain Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Target Disease Prevalence
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement Framework
    • 7.5.7.5. Denmark Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Target Disease Prevalence
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement Framework
    • 7.5.8.5. Sweden Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Target Disease Prevalence
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement Framework
    • 7.5.9.5. Norway Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement Framework
    • 7.6.2.5. Japan Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement Framework
    • 7.6.3.5. China Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement Framework
    • 7.6.4.5. India Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Target Disease Prevalence
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement Framework
    • 7.6.5.5. Australia Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Target Disease Prevalence
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement Framework
    • 7.6.6.5. South Korea Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Target Disease Prevalence
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement Framework
    • 7.6.7.5. Thailand Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Target Disease Prevalence
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement Framework
    • 7.7.2.5. Japan Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Target Disease Prevalence
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement Framework
    • 7.7.3.5. China Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East and Africa
  • 7.8.1. Middle East and Africa Hearing Loss Disease Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Target Disease Prevalence
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement Framework
    • 7.8.2.5. South Africa Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Target Disease Prevalence
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement Framework
    • 7.8.3.5. Saudi Arabia Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Target Disease Prevalence
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement Framework
    • 7.8.4.5. UAE Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Target Disease Prevalence
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement Framework
    • 7.8.5.5. Kuwait Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Novartis AG
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Spiral Therapeutics (Otonomy, Inc.)
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Acousia Therapeutics Gmbh
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Sensorion
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Audina Hearing Instruments, Inc.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Ws Audiology A/S
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. audifon Gmbh & Co. Kg
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. MED-EL Medical Electronics
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Demant A/S
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Sonova
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives